جستجوی استاد راهنمای دانشگاهی

• Medical Physics
• Radiation Oncology
• Quantitative Ultrasound
• +۵ مورد دیگر

Roxana Vlad is an Assistant Professor in the Interdisciplinary Science program within the Faculty of Science at McMaster University, and also serves as a Medical Physicist at Juravinski Hospital and Cancer Centre. Her work bridges academic research with clinical applications in radiation physics and medical imaging, maintaining active scholarly output from 1999 through 2025. Dr. Vlad's research focuses on medical physics applications, particularly in radiation oncology and quantitative ultrasound. Her work centers on developing and applying ultrasound techniques for monitoring cancer treatment responses, especially radiation therapy. She has pioneered methods for using high-frequency ultrasound spectroscopy to detect cellular changes during apoptosis and other cell death processes, enabling real-time monitoring of treatment efficacy. Her research spans from basic science investigations of cellular changes to clinical applications in cancer treatment monitoring, with publications mapped across 554 scientific subdisciplines. Analysis of Dr. Vlad's publication record reveals a consistent progression from fundamental studies of cellular changes during radiation therapy to increasingly sophisticated clinical applications. Key themes include the development of ultrasound spectroscopy for detecting DNA damage, 3D ultrasound reconstruction techniques, and integration with other imaging modalities like MRI for comprehensive treatment assessment. Her recent work has expanded to include clinical implementation of new radiation therapy technologies (2022 publications on Varian Halcyon systems) and even mental health assessment in medical education (2025 publication on Romanian medical students). Referenced in 19 patents for some publications 79 readers on Mendeley for key works Strong presence in Radiology (40.7% of activity), Radiation Therapy (18.5%), and Instrumentation (14.8%) As an educator, Dr. Vlad teaches courses including Radiation Oncology Physics II (MEDPHYS 788), Clinical Applications of Physics in Medicine (MEDPHYS 4T03), and Integrated Science I (ISCI 1A24A). She actively seeks to involve students in research that "can bring innovations into the clinical environment of radiation physics." Her clinical role at Juravinski Hospital and Cancer Centre directly informs her research direction and ensures practical relevance to patient care.

Mark Oldhamمشاهده پروفایل

استاد

• FLASH radiation therapy
• Radiation and Immunotherapy
• Radiation Therapy Enhanced by Cherenkov photo-Activation (RECA)
• +۶ مورد دیگر

Mark Oldham is Professor of Radiation Oncology and Professor of Physics at Duke University, where he also serves as Director of the Duke Medical Physics MS/PhD Graduate Program and is a Member of the Duke Cancer Institute. His academic career spans over three decades with progressive appointments from Instructor to full Professor in Radiation Oncology. Dr. Oldham received his Ph.D. from Newcastle University (United Kingdom) in 1991. His research interests focus on innovative approaches to radiation therapy, particularly FLASH radiation therapy using the Duke High Intensity Gamma Source (HIGS), radiation and immunotherapy utilizing mini-grids, Radiation Therapy Enhanced by Cherenkov photo-Activation (RECA), and comprehensive 3D dosimetry systems. His work has been recognized with multiple Paper of the Year awards from SEAAPM and the prestigious Farrington Daniel Award from AAPM. His recent publications demonstrate a strong focus on 3D dosimetry systems, radiation therapy verification techniques, and novel cancer treatment approaches. His research integrates advanced dosimetry methods with innovative radiation therapy techniques to improve cancer treatment outcomes. His work on polymer gel dosimetry, optical CT scanning, and radiation-immunotherapy combinations represents cutting-edge developments in the field. Dr. Oldham's scientific achievements have been recognized through multiple awards including the Paper of the Year (2018, 2017), Farrington Daniel Award (2016, 2002), Excellence in Teaching (2014), Excellence in Mentoring (2011), and Fellow of the AAPM (2010). He has also received the Director's Award for Exemplary Service multiple times. As a principal investigator and co-investigator, Dr. Oldham has secured significant research funding from the National Institutes of Health, National Institute of Dental and Craniofacial Research, and Ian's Friends Foundation. His current research portfolio includes exploring synthetic lethality with high energy electron FLASH radiation beams, super-FLASH therapy for pediatric brain tumors, and radiation protection mechanisms. He serves on the Board of Directors of the American Association of Medical Physics and has made significant contributions to medical physics education through his leadership of Duke's Medical Physics Graduate Program.

• Radiation Oncology
• Medical Physics
• Image-Guided Radiation Therapy
• +۳ مورد دیگر

Srijit Kamath serves as Assistant Professor of Therapeutic Radiology at Yale School of Medicine, Yale University, with additional responsibility as Regional Chief Physicist overseeing operations at Trumbull Radiation Oncology, Smilow Cancer Hospital Care Center at Greenwich, and Griffin Hospital Lawrence and Memorial Cancer Center. His clinical leadership ensures physics standards across Yale's integrated cancer care network including Smilow Cancer Hospital and Yale Gamma Knife Center. His academic foundation includes: Medical Physics Residency, University of Florida (2010) PhD, University of Florida (2005) MS, University of Florida (2000) Dr. Kamath's research program centers on computational optimization of radiation therapy delivery, with seminal contributions to intensity-modulated radiation therapy (IMRT) field splitting algorithms, multileaf collimator sequencing, and deformable image registration. His work addresses critical challenges in treatment delivery efficiency while maintaining dosimetric accuracy, particularly for large-field treatments where conventional approaches risk underdosage at field junctions. He has pioneered methods to eliminate tongue-and-groove effects and optimize feathering techniques for seamless dose distributions. Analysis of his 15 most recent publications (2003-2011) reveals a consistent trajectory from foundational work on leaf sequencing algorithms to sophisticated solutions for deformable image registration and CBCT system optimization. His comparative studies of XVI and OBI CBCT systems established critical benchmarks for image quality in radiation therapy guidance, while his field-splitting algorithms remain clinically implemented for complex treatment geometries. The research demonstrates exceptional focus on translating computational advances into practical clinical workflows. No scientific awards or honors were documented in the available information. As Regional Chief Physicist, Dr. Kamath directs medical physics services across multiple community cancer centers, ensuring compliance with safety standards and optimal implementation of advanced techniques like stereotactic body radiation therapy (SBRT). While student advising activities aren't specified, his role in Yale's residency training program involves mentoring medical physics residents through clinical rotations. The absence of grant documentation suggests primary focus on clinical service and technical innovation rather than externally funded research. He operates within Yale's comprehensive radiation oncology infrastructure, collaborating with multidisciplinary teams at Smilow Cancer Hospital and affiliated centers to integrate advanced imaging and treatment technologies. His work directly supports the clinical mission of delivering precision radiation therapy through physics-driven quality assurance and process optimization.

Paul Blackمشاهده پروفایل

استادیار

• Radiation Oncology
• Medical Physics
• Stereotactic Radiosurgery
• +۳ مورد دیگر

Paul Black serves as an Assistant Professor in the Department of Radiation Oncology at Wake Forest University School of Medicine, with concurrent affiliation at the Comprehensive Cancer Center (CCC), focusing on advancing precision radiation therapy through innovative dosimetric and imaging techniques. Educational Background: BS, College of William and Mary, 2007 PhD, University of Rochester, 2012 His research spans medical physics and radiation oncology, emphasizing stereotactic radiosurgery optimization, real-time treatment verification via Cherenkov imaging, and spacer technology for prostate radiotherapy. Key investigations include Gamma Knife dose-rate effects for vestibular schwannomas, hydrogel spacer modeling to minimize rectal toxicity, and preclinical irradiator commissioning, all targeting enhanced therapeutic precision and patient safety through quantitative dosimetry. Publication analysis reveals consistent focus on translational medical physics, with 2018-2019 works demonstrating progression from clinical outcomes (Neurosurgery) to technical verification systems (Medical Physics), highlighting cross-disciplinary integration of engineering principles with oncology applications across brain and prostate cancer treatment modalities.

Imran Rizviمشاهده پروفایل

دانشیار

• Biomedical Imaging
• Pharmacoengineering
• Cancer Therapeutics
• +۳ مورد دیگر

Dr. Imran Rizvi is an Associate Professor in the Department of Biomedical Engineering at the University of North Carolina at Chapel Hill. He holds affiliations with the Lineberger Comprehensive Cancer Center, the Center for Environmental Health and Susceptibility, and the Functional Tissue Engineering Program at NC State University. His research focuses on imaging and therapeutic applications of light, targeted drug delivery, and bioengineered 3D models for cancer. Key areas include overcoming drug resistance in ovarian and pancreatic cancers through photodynamic therapy (PDT) combinations and investigating environmental toxin impacts (e.g., PFAS) on cancer treatment efficacy. Dr. Rizvi’s education includes a Ph.D. in Engineering Sciences from Dartmouth College, an M.S. in Tumor Biology from Georgetown University, and a B.A. from Johns Hopkins University. He previously served as an Assistant Professor of Dermatology at Harvard Medical School and an Assistant Biomedical Engineer at Massachusetts General Hospital’s Wellman Center for Photomedicine. His research interests emphasize PDT-based therapies, biomodulatory strategies to enhance drug delivery, and the role of mechanical forces (e.g., fluid shear stress) in tumor resistance. He has explored synergistic treatments combining PDT with chemotherapy, immunotherapy, and nanomedicines. Recent work highlights mechanisms by which PFAS exposure induces platinum resistance and the use of photodynamic priming to counteract such effects. Dr. Rizvi teaches courses in biomedical engineering, including BMME 302 (Human Physiology: Mechanical Analysis) and BMME 527 (Targeted Photomedicine). His contributions span over 60 peer-reviewed publications and book chapters, with a focus on PDT, molecular targeting, and cancer microenvironment dynamics.

• Ultraviolet Radiation Epidemiology
• Skin Cancer Prevention
• Public Health Interventions
• +۴ مورد دیگر

Dr. Simone L. Harrison is an Associate Professor at James Cook University's College of Public Health, Medical and Veterinary Sciences, specializing in the School of Public Health and Tropical Medicine. Her research focuses on ultraviolet radiation epidemiology and skin cancer prevention in tropical environments, with particular emphasis on childhood exposure risks and behavioral interventions. She leads major longitudinal studies including the 24-year Townsville preschool cohort and the North Queensland Sun-Safe Clothing randomized controlled trial. Her research interests center on UV radiation exposure dynamics in tropical climates, melanoma risk factors across the lifespan, and evidence-based sun protection strategies. She has pioneered methodologies for measuring personal UV exposure through electronic journals and parametric human modeling, while developing rigorous frameworks for evaluating sun-protective clothing efficacy. Her work bridges environmental science, public health policy, and clinical dermatology to address Australia's high skin cancer burden. Analysis of her recent publications reveals a strategic shift from basic UV measurement techniques toward behavioral interventions and policy implementation. Her work increasingly examines occupational exposures (teachers, outdoor workers), childhood protection strategies, and the complex relationship between UV exposure, vitamin D synthesis, and immune function. The tropical Queensland context provides a critical natural laboratory for studying extreme UV environments. Dr. Harrison actively collaborates with international research groups including the EPI-HPV-UV-CA consortium, contributing to multicenter studies on post-transplant skin cancer and papillomavirus interactions. Her research informs Australian sun protection standards and school policies, with demonstrated impact on public health guidelines for early childhood settings and outdoor workplaces. Her laboratory work integrates environmental monitoring, human behavioral observation, and computational modeling to create comprehensive risk assessment frameworks. Current projects examine dynamic shade characteristics of urban infrastructure, keratinocyte cancer risk factors, and immunosuppressive effects of UV radiation on vaccine responses, positioning her at the forefront of translational photobiology research.

Paul Blackمشاهده پروفایل

استادیار

• Radiation Oncology
• Medical Physics
• Dosimetry
• +۵ مورد دیگر

Paul Black, PhD, is an Assistant Professor in the Department of Radiation Oncology at Wake Forest University School of Medicine in Winston-Salem. He is also affiliated with the Comprehensive Cancer Center (CCC), contributing to translational and clinical research in radiation therapy. Education: BS, College of William and Mary, 2007 PhD, University of Rochester, 2012 Dr. Black's research lies at the intersection of medical physics and radiation oncology, with a focus on improving the precision and safety of radiotherapy. His work spans dosimetric verification , image-guided radiotherapy , and Cherenkov-based treatment monitoring . He has developed models for hydrogel spacer efficacy in prostate SBRT and has conducted extensive commissioning studies on small animal irradiators for preclinical research. His recent publications demonstrate a strong trend toward technical innovation in radiation delivery and dosimetric accuracy , particularly in stereotactic and image-guided contexts. The work integrates advanced imaging, 3D dosimetry, and clinical outcomes analysis. Scientific Awards: Dr. Black actively contributes to research in radiation oncology physics, though no formal advising roles or grant funding are mentioned in the available text. His collaborations include physicists and clinicians across multiple institutions, indicating an integrated team-based research approach. He is involved in research efforts within the Comprehensive Cancer Center, particularly in developing and validating novel dosimetry and imaging techniques for both clinical and preclinical applications.

Brian Hrycushkoمشاهده پروفایل

دانشیار

• Medical Physics
• Brachytherapy
• Radiation Oncology
• +۴ مورد دیگر

Brian Hrycushko, Ph.D. , is an Associate Professor in the Department of Radiation Oncology at UT Southwestern Medical Center , where he leads the brachytherapy program —the most comprehensive in North Texas. He is a faculty member in the Division of Medical Physics & Engineering and holds a Ph.D. from the University of Texas Health Science Center at San Antonio after completing residency training at UT Southwestern . Research Interests Dr. Hrycushko specializes in brachytherapy with a focus on low-dose-rate (LDR) and high-dose-rate (HDR) techniques, particularly for prostate , cervical , and gynecological cancers . His work integrates medical physics with radiation biology to optimize dose distribution and reduce normal tissue complications. He employs machine learning and 3D printing for predictive modeling and training phantom fabrication. His research also extends to stereotactic ablative radiotherapy (SABR) , spinal nerve tolerance , and online adaptive radiation therapy . Publications Dr. Hrycushko’s publications reflect advancements in brachytherapy planning , AI-driven dose optimization , and radiation toxicity prediction . Recent works address online adaptive cervical cancer treatment , 3D-printed applicators , and rectal toxicity modeling . Earlier studies explore spinal nerve dose thresholds and radioprotective hypothermia . Professional Affiliations American Association of Physicists in Medicine (AAPM) American Society for Radiation Oncology (ASTRO) American Brachytherapy Society (ABS) (active member of ABR Educational Committee, Education GU Subcommittee, and Educational Physics Subcommittee)

• Medical Robotics
• Artificial Intelligence
• Radiosurgery
• +۳ مورد دیگر

Prof. Achim Schweikard is a Full Professor at the University of Lübeck's Institute for Robotics and Cognitive Systems, where he has led pioneering research since 2002. His academic journey spans Stanford University's neurosurgery and computer science departments and Technical University of Munich, establishing him as a leading figure in medical technology translation. His research focuses on Medical Robotics and Artificial Intelligence with transformative clinical applications. Key achievements include inventing correlation-based tracking for cancer radiosurgery (now global standard of care) and developing stereotactic arrhythmia radioablation (STAR) protocols. Current projects address critical challenges in cardiac radioablation through the RAVENTA multicenter trial, MATRIX-VT imaging fusion study, and SonoBox robotic ultrasound system for pediatric diagnostics. His publication record shows sustained high impact with 15+ articles in 2023-2025 in top journals including Radiotherapy and Oncology and Heart Rhythm. These works demonstrate progression from foundational robotics to clinical implementation, with recent focus on cardiac motion estimation, target transfer automation, and S-ICD patient treatment solutions. As Academic Director of UNI Luebeck's Grad School (2025), he oversees doctoral training while leading the Robotics Laboratory (RobLab). The lab maintains active grants supporting: RAVENTA trial: German multicenter feasibility study for ventricular tachycardia radioablation DYNAMIC phantom development for end-to-end treatment validation ECG-gated 4D CT motion modeling for precision targeting Landmark-based ultrasound-CT fusion techniques Students gain comprehensive experience across the medical technology pipeline - from hardware prototyping to clinical trial participation - within an internationally collaborative environment spanning the STOPSTORM.eu consortium and multiple EU research networks.